SCHEMBL13912151

SCHEMBL13912151

O=C1C(Cl)=C(N2CCCC2)C(=O)N1c1ccc(Cl)c(Cl)c1

nearest known ligand 0.97

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2A1 Q16548 9/20 0.77
ALDH1A1 P00352 3/20 0.77
RAD51 Q06609 2/20 0.77
MAPT P10636 2/20 0.77
RAD1 O60671 1/20 0.77
LMNA P02545 1/20 0.77
BCL2 P10415 1/20 0.77
ALOX12 P18054 1/20 0.77
BID P55957 1/20 0.77
BCL2L1 Q07817 1/20 0.77
BCL2L2 Q92843 1/20 0.77
L3MBTL1 Q9Y468 4/20 0.68
POLB P06746 2/20 0.68
MEN1 O00255 1/20 0.68
KMT2A Q03164 1/20 0.68
HPGD P15428 2/20 0.64
ALOX15 P16050 2/20 0.64
HSD17B10 Q99714 2/20 0.64
TSHR P16473 1/20 0.64
MAPK1 P28482 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13912138 0.98 BCL2A1 (0.75) BCL2A1ALDH1A1RAD51MAPTRAD1
SCHEMBL4257590 0.87 BCL2A1 (1.00) BCL2A1ALDH1A1RAD51MAPTRAD1
SCHEMBL13186471 0.87 RAD51 (1.00) BCL2A1ALDH1A1RAD51MAPTRAD1
SCHEMBL13912158 0.84 BCL2A1 (1.00) BCL2A1ALDH1A1RAD51MAPTRAD1
SCHEMBL13912163 0.83 BCL2A1 (0.71) BCL2A1ALDH1A1RAD51MAPTRAD1
SCHEMBL13912155 0.82 BCL2A1 (1.00) BCL2A1ALDH1A1RAD51MAPTRAD1
SCHEMBL13912162 0.81 BCL2A1 (1.00) BCL2A1ALDH1A1RAD51MAPTRAD1
SCHEMBL15347242 0.80 L3MBTL1 (0.97) ALDH1A1RAD51MAPTALOX12L3MBTL1
SCHEMBL10834724 0.80 BCL2A1 (0.69) BCL2A1ALDH1A1RAD51MAPTRAD1
SCHEMBL17208335 0.80 RAD51 (0.64) BCL2A1ALDH1A1RAD51MAPTRAD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069324-A1 CHEMICAL INHIBITORS OF BFL-1 AND RELATED METHODS THE BURNHAM INSTITUTE (US) 2009-03-12 US disclosed
US-20090069324-A1 CHEMICAL INHIBITORS OF BFL-1 AND RELATED METHODS THE BURNHAM INSTITUTE (US) 2009-03-12 US disclosed
WO-2008157003-A2 CHEMICAL INHIBITORS OF BFL-1 AND RELATED METHODS THE BURNHAM INSTITUTE (US) 2008-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069324-A1 CHEMICAL INHIBITORS OF BFL-1 AND RELATED METHODS TMBIM6, BCL2L1, BCL2L11 BCL2A1 11/4885ALDH1A1 2702/4885RAD51 380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.